Cargando…
Revisiting Exclusion of Prior Cancer in Clinical Trials of Male Breast Cancer
Background: Eligibility criteria for cancer clinical trials present challenges to enrollment. Many trials exclude patients with a prior cancer. This common practice may be especially detrimental to trials of rare cancers, such as male breast cancer, that struggle to accrue adequate numbers of partic...
Autores principales: | Rathod, Aniruddha, Murphy, Caitlin C., Rahimi, Asal, Pruitt, Sandi L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088891/ https://www.ncbi.nlm.nih.gov/pubmed/37056393 http://dx.doi.org/10.7150/jca.80740 |
Ejemplares similares
-
Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer
por: Pruitt, Sandi L, et al.
Publicado: (2017) -
Exclusion of Male Patients in Breast Cancer Clinical Trials
por: Duma, Narjust, et al.
Publicado: (2018) -
Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials
por: Patel, Roshal R., et al.
Publicado: (2022) -
Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
por: Al-Husseini, Muneer J., et al.
Publicado: (2019) -
Revisiting MIS-C: Extending the Exclusions
por: Mishra, Ambrish Kumar, et al.
Publicado: (2022)